Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Fisher

Showing results (181-190 of 216) with videos related to

Pageof 22
Sort By:
Journal of Medicinal Chemistry|July 4, 2009
Identification of inhibitors of checkpoint kinase 1 through template screeningThomas P Matthews, Suki Klair, Samantha Burns, et al.
Haematologica|April 2, 2009
CD4 counts and the risk of systemic non-Hodgkin's lymphoma in individuals with HIV in the UKMark Bower, Martin Fisher, Teresa Hill, et al.
The New England Journal of Medicine|January 18, 2013
Short-course antiretroviral therapy in primary HIV infection, Sarah Fidler, Kholoud Porter, et al.
The Lancet. Public Health|March 17, 2017
Socioeconomic status and treatment outcomes for individuals with HIV on antiretroviral treatment in the UK: cross-sectional and longitudinal analysesLisa S Burch, Colette J Smith, Jane Anderson, et al.
Journal of Neurovirology|May 20, 2016
Discordant CSF/plasma HIV-1 RNA in patients with unexplained low-level viraemiaSam Nightingale, Anna Maria Geretti, Apostolos Beloukas, et al.
European Journal of Neurology|December 17, 2010
HIV-associated central nervous system diseases in the recent combination antiretroviral therapy era, Lucy Garvey, Alan Winston, et al.
AIDS (London, England)|September 23, 2009
Tuberculosis among people with HIV infection in the United Kingdom: opportunities for prevention?Alison D Grant, Loveleen Bansi, Jonathan Ainsworth, et al.
Elife|September 14, 2014
HIV-1 DNA predicts disease progression and post-treatment virological controlJames P Williams, Jacob Hurst, Wolfgang Stöhr, et al.
The Journal of Antimicrobial Chemotherapy|February 26, 2013
Effects of age on antiretroviral plasma drug concentration in HIV-infected subjects undergoing routine therapeutic drug monitoringAlan Winston, Sophie Jose, Sara Gibbons, et al.
BMJ (Clinical Research Ed.)|October 13, 2011
Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) StudyMargaret May, Mark Gompels, Valerie Delpech, et al.
Pageof 22

Showing results (181-190 of 216) with videos related to

Sort By:
Pageof 22
Journal of Medicinal Chemistry|July 4, 2009
Identification of inhibitors of checkpoint kinase 1 through template screeningThomas P Matthews, Suki Klair, Samantha Burns, et al.
Haematologica|April 2, 2009
CD4 counts and the risk of systemic non-Hodgkin's lymphoma in individuals with HIV in the UKMark Bower, Martin Fisher, Teresa Hill, et al.
The New England Journal of Medicine|January 18, 2013
Short-course antiretroviral therapy in primary HIV infection, Sarah Fidler, Kholoud Porter, et al.
The Lancet. Public Health|March 17, 2017
Socioeconomic status and treatment outcomes for individuals with HIV on antiretroviral treatment in the UK: cross-sectional and longitudinal analysesLisa S Burch, Colette J Smith, Jane Anderson, et al.
Journal of Neurovirology|May 20, 2016
Discordant CSF/plasma HIV-1 RNA in patients with unexplained low-level viraemiaSam Nightingale, Anna Maria Geretti, Apostolos Beloukas, et al.
European Journal of Neurology|December 17, 2010
HIV-associated central nervous system diseases in the recent combination antiretroviral therapy era, Lucy Garvey, Alan Winston, et al.
AIDS (London, England)|September 23, 2009
Tuberculosis among people with HIV infection in the United Kingdom: opportunities for prevention?Alison D Grant, Loveleen Bansi, Jonathan Ainsworth, et al.
Elife|September 14, 2014
HIV-1 DNA predicts disease progression and post-treatment virological controlJames P Williams, Jacob Hurst, Wolfgang Stöhr, et al.
The Journal of Antimicrobial Chemotherapy|February 26, 2013
Effects of age on antiretroviral plasma drug concentration in HIV-infected subjects undergoing routine therapeutic drug monitoringAlan Winston, Sophie Jose, Sara Gibbons, et al.
BMJ (Clinical Research Ed.)|October 13, 2011
Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) StudyMargaret May, Mark Gompels, Valerie Delpech, et al.
Pageof 22